{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:09:56Z","timestamp":1779379796581,"version":"3.53.1"},"reference-count":51,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Canadian Institute for Health Research and the Southeastern Ontario AHSC AFP Innovation Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Leptin, a hormone produced by adipose tissue, stimulates bone production of FGF-23 in preclinical studies and thus may impact vitamin D metabolism. We investigated the association between longitudinal changes in visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) and vitamin D metabolism in patients receiving hemodialysis. This cohort study of clinical trial participants included adult patients receiving hemodialysis who were not taking active vitamin D therapy at baseline (n\u2009=\u200930) and 1\u00a0yr (n\u2009=\u200926). Visceral adipose tissue and SAT cross-sectional area was measured by multidetector CT scanner and SliceOMatic software. Vitamin D metabolites were measured with mass spectroscopy and expressed as vitamin D metabolite ratios. FGF-23, leptin, and adiponectin were measured by ELISA. Spearman correlation and Wilcoxon rank-sum tests were used to evaluate baseline and relative change variables. Linear regression was used to evaluate the relationship between changes in FGF-23 and leptin. The progression toward increased fat in the visceral area (VSR) was associated with an increase in FGF-23 and leptin and a decline in the ratio between the active vitamin D hormone, 1,25(OH)2D3, and the 25(OH)D3 precursor molecule. The relative change in leptin as well as the leptin to adiponectin ratio was associated with the change in FGF-23 controlling for baseline FGF-23 and PTH. Adipose tissue may contribute to altered vitamin D metabolism. This effect appeared primarily related to VAT and the progression toward increased fat in the viscera. Whether the changes in vitamin D metabolism are directly related to the observed changes in FGF-23 and leptin, or a local effect within adipocytes, requires further study. Consideration of body composition may be one step toward personalizing the care and treatment of CKD-associated mineral and bone disorders based on individual characteristics.<\/jats:p>","DOI":"10.1093\/jbmr\/zjag051","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:48:37Z","timestamp":1773233317000},"source":"Crossref","is-referenced-by-count":0,"title":["Visceral adipose tissue is associated with changes in leptin, FGF-23 and vitamin D metabolism in chronic kidney disease"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6431-3127","authenticated-orcid":false,"given":"Rachel M","family":"Holden","sequence":"first","affiliation":[{"name":"Department of Medicine, Queen\u2019s University , Kingston, ON K7L3N6 ,","place":["Canada"]},{"name":"Department of Biomedical and Molecular Sciences, Queen\u2019s University , Kingston, ON K7L3N6 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A","family":"Norman","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Queen\u2019s University , Kingston, ON K7L3N6 ,","place":["Canada"]},{"name":"Kingston General Hospital Health Research Institute, Kingston Health Sciences Center , Kingston, ON K7L2V7 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6431-5077","authenticated-orcid":false,"given":"Mandy E","family":"Turner","sequence":"additional","affiliation":[{"name":"Center for Interdisciplinary Cardiovascular Sciences, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, MA 02115 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0000-8806","authenticated-orcid":false,"given":"Deborah","family":"Zimmerman","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Ottawa , Ottawa, ON K1H8L6 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Moist","sequence":"additional","affiliation":[{"name":"Schulich School of Medicine and Dentistry, Western University , London, ON N6A5C1 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenville","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Molecular Sciences, Queen\u2019s University , Kingston, ON K7L3N6 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Molecular Sciences, Queen\u2019s University , Kingston, ON K7L3N6 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Petkovich","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Molecular Sciences, Queen\u2019s University , Kingston, ON K7L3N6 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Ward","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Molecular Sciences, Queen\u2019s University , Kingston, ON K7L3N6 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daren K","family":"Heyland","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Queen\u2019s University , Kingston, ON K7L3N6 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Adams","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Molecular Sciences, Queen\u2019s University , Kingston, ON K7L3N6 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Mourtzakis","sequence":"additional","affiliation":[{"name":"Faculty of Health, University of Waterloo , Waterloo, ON N2L3G1 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"issue":"1","key":"2026052111520472500_ref1","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1172\/JCI111971","article-title":"Evidence for alteration of the vitamin D-endocrine system in obese subjects","volume":"76","author":"Bell","year":"1985","journal-title":"J Clin Invest"},{"issue":"3","key":"2026052111520472500_ref2","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/ajcn\/72.3.690","article-title":"Decreased bioavailability of vitamin D in obesity","volume":"72","author":"Wortsman","year":"2000","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"2026052111520472500_ref3","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s11154-023-09831-3","article-title":"Vitamin D status and supplementation before and after bariatric surgery: recommendations based on a systematic review and meta-analysis","volume":"24","author":"Giustina","year":"2023","journal-title":"Rev Endocr Metab Disord"},{"issue":"7","key":"2026052111520472500_ref4","first-page":"e27335","article-title":"Factors showing the growing relation between vitamin D, metabolic syndrome, and obesity in the adult population: a systematic review","volume":"14","author":"Kauser","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"2026052111520472500_ref5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2337\/db09-1011","article-title":"Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study","volume":"59","author":"Cheng","year":"2010","journal-title":"Diabetes"},{"issue":"4","key":"2026052111520472500_ref6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/obr.12239","article-title":"Obesity and vitamin D deficiency: a systematic review and meta-analysis","volume":"16","author":"Pereira-Santos","year":"2015","journal-title":"Obes Rev"},{"key":"2026052111520472500_ref7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.metabol.2018.12.010","article-title":"Vitamin D supplementation in obesity and during weight loss: a review of randomized controlled trials","volume":"92","author":"Bassatne","year":"2019","journal-title":"Metabolism"},{"issue":"5","key":"2026052111520472500_ref8","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1210\/clinem\/dgaa981","article-title":"Effects of vitamin D3 supplementation on body composition in the VITamin D and OmegA-3 TriaL (VITAL)","volume":"106","author":"Chou","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026052111520472500_ref9","doi-asserted-by":"publisher","first-page":"e2250681","DOI":"10.1001\/jamanetworkopen.2022.50681","article-title":"Association of body weight with response to vitamin D supplementation and metabolism","volume":"6","author":"Tobias","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2026052111520472500_ref10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ijo.2011.119","article-title":"The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications","volume":"36","author":"Earthman","year":"2012","journal-title":"Int J Obes"},{"issue":"2","key":"2026052111520472500_ref11","doi-asserted-by":"publisher","first-page":"582S","DOI":"10.1093\/ajcn\/88.2.582S","article-title":"Pharmacokinetics of vitamin D toxicity","volume":"88","author":"Jones","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"2026052111520472500_ref12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1681\/ASN.2020050625","article-title":"Differences in 25-hydroxyvitamin D clearance by eGFR and race: a pharmacokinetic study","volume":"32","author":"Hsu","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2026052111520472500_ref13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1053\/j.ajkd.2014.02.015","article-title":"Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials","volume":"64","author":"de Boer","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2026052111520472500_ref14","doi-asserted-by":"publisher","first-page":"106047","DOI":"10.1016\/j.jsbmb.2021.106047","article-title":"Validation of the 24,25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 ratio as a biomarker of 25-hydroxyvitamin D3 clearance","volume":"217","author":"Hsu","year":"2022","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026052111520472500_ref15","doi-asserted-by":"publisher","first-page":"106252","DOI":"10.1016\/j.jsbmb.2023.106252","article-title":"Genomic mechanisms controlling renal vitamin D metabolism","volume":"228","author":"Meyer","year":"2023","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026052111520472500_ref16","doi-asserted-by":"publisher","first-page":"106207","DOI":"10.1016\/j.jsbmb.2022.106207","article-title":"The 1,24,25(OH)3D3 metabolite in clinical and experimental CKD: impact of calcitriol treatment","volume":"226","author":"Turner","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"2026052111520472500_ref17","doi-asserted-by":"publisher","first-page":"10925","DOI":"10.1038\/s41598-022-15033-9","article-title":"The metabolism of 1,25(OH)2D3 in clinical and experimental kidney disease","volume":"12","author":"Turner","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"2026052111520472500_ref18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/ATVBAHA.110.214619","article-title":"Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals","volume":"31","author":"Mirza","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2026052111520472500_ref19","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1210\/jc.2016-3563","article-title":"Fibroblast growth factor 23, mineral metabolism, and adiposity in normal kidney function","volume":"102","author":"Zaheer","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026052111520472500_ref20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1053\/j.jrn.2017.12.010","article-title":"Fibroblast growth factor 23 is associated with adiposity in patients receiving hemodialysis: possible cross talk between bone and adipose tissue","volume":"28","author":"Chiang","year":"2018","journal-title":"J Ren Nutr"},{"issue":"1","key":"2026052111520472500_ref21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12933-018-0786-9","article-title":"Correlations between serum concentration of three bone-derived factors and obesity and visceral fat accumulation in a cohort of middle aged men and women","volume":"17","author":"Xu","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"2026052111520472500_ref22","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1210\/jc.2011-2280","article-title":"Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity","volume":"97","author":"Grethen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026052111520472500_ref23","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/jbmr.65","article-title":"Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice","volume":"25","author":"Tsuji","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2026052111520472500_ref24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocr Rev"},{"key":"2026052111520472500_ref25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.amjcard.2020.10.053","article-title":"Relation of adiponectin to cardiovascular events and mortality in patients with acute coronary syndrome","volume":"140","author":"Nomura","year":"2021","journal-title":"Am J Cardiol"},{"issue":"2","key":"2026052111520472500_ref26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1053\/j.ajkd.2015.02.325","article-title":"Association of adiponectin with body composition and mortality in hemodialysis patients","volume":"66","author":"Rhee","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"2026052111520472500_ref27","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/dom.12905","article-title":"Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial","volume":"19","author":"Bergmark","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"2026052111520472500_ref28","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1093\/ndt\/gfx344","article-title":"Circulating adiponectin modifies the FGF23 response to vitamin D receptor activation: a post hoc analysis of a double-blind, randomized clinical trial","volume":"33","author":"Spoto","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2026052111520472500_ref29","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ki.2012.421","article-title":"The adipose tissue production of adiponectin is increased in end-stage renal disease","volume":"83","author":"Martinez Cantarin","year":"2013","journal-title":"Kidney Int"},{"issue":"10","key":"2026052111520472500_ref30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/biomedicines10102642","article-title":"New insights into adiponectin and leptin roles in chronic kidney disease","volume":"10","author":"Coimbra","year":"2022","journal-title":"Biomedicines"},{"issue":"11","key":"2026052111520472500_ref31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/toxins17110525","article-title":"Leptin and adiponectin as uremic adipokines: associations with survival in a prospective hemodialysis cohort","volume":"17","author":"Bui","year":"2025","journal-title":"Toxins"},{"issue":"1","key":"2026052111520472500_ref32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCRESAHA.120.314458","article-title":"Adiponectin, leptin and cardiovascular disorders","volume":"128","author":"Zhao","year":"2021","journal-title":"Circ Res"},{"issue":"9","key":"2026052111520472500_ref33","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.numecd.2012.06.004","article-title":"Visceral obesity assessed by computed tomography predicts cardiovascular events in chronic kidney disease patients","volume":"23","author":"Kamimura","year":"2013","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"2026052111520472500_ref34","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.pcad.2018.07.001","article-title":"Obesity paradox in advanced kidney disease: from bedside to the bench","volume":"61","author":"Naderi","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"issue":"10","key":"2026052111520472500_ref35","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1007\/s00125-012-2639-5","article-title":"The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk","volume":"55","author":"Kaess","year":"2012","journal-title":"Diabetologia"},{"issue":"1","key":"2026052111520472500_ref36","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1186\/s12889-024-19358-0","article-title":"The association between the visceral to subcutaneous abdominal fat ratio and the risk of cardiovascular diseases: a systematic review","volume":"24","author":"Emamat","year":"2024","journal-title":"BMC Public Health"},{"issue":"3","key":"2026052111520472500_ref37","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/ndt\/gfac191","article-title":"Inhibit progression of coronary artery calcification with vitamin K in hemodialysis patients (the iPACK-HD study): a randomized, placebo-controlled multi-center, pilot trial","volume":"38","author":"Holden","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"2026052111520472500_ref38","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/jbmr.4306","article-title":"Differential diagnosis of vitamin D-related hypercalcemia using serum vitamin D metabolite profiling","volume":"36","author":"Kaufmann","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2026052111520472500_ref39","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.clnu.2020.01.008","article-title":"Automated body composition analysis of clinically acquired computed tomography scans using neural networks","volume":"39","author":"Paris","year":"2020","journal-title":"Clin Nutr"},{"issue":"6","key":"2026052111520472500_ref40","doi-asserted-by":"publisher","first-page":"e0198481","DOI":"10.1371\/journal.pone.0198481","article-title":"Phosphorus restriction does not prevent the increase in fibroblast growth factor 23 elicited by high fat diet","volume":"13","author":"Rios","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"2026052111520472500_ref41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1507\/endocrj.EJ21-0185","article-title":"Role of adiponectin in the relationship between visceral adiposity and fibroblast growth factor 23 in non-diabetic men with normal kidney function","volume":"69","author":"Natsuki","year":"2022","journal-title":"Endocr J"},{"issue":"12","key":"2026052111520472500_ref42","doi-asserted-by":"publisher","first-page":"E599","DOI":"10.1002\/oby.20464","article-title":"Serum 25(OH) vitamin D concentration changes after Roux-en-Y gastric bypass surgery","volume":"21","author":"Beckman","year":"2013","journal-title":"Obesity"},{"issue":"5","key":"2026052111520472500_ref43","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/ijo.2012.112","article-title":"Expression of vitamin D-metabolizing enzymes in human adipose tissue -- the effect of obesity and diet-induced weight loss","volume":"37","author":"Wamberg","year":"2013","journal-title":"Int J Obes"},{"key":"2026052111520472500_ref44","doi-asserted-by":"publisher","first-page":"105564","DOI":"10.1016\/j.jsbmb.2019.105564","article-title":"Obesity and leptin influence vitamin D metabolism and action in human marrow stromal cells","volume":"198","author":"Li","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"2026052111520472500_ref45","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.numecd.2023.03.023","article-title":"Glucagon-like peptide 1 receptor agonists in end-staged kidney disease and kidney transplantation: a narrative review","volume":"33","author":"Clemens","year":"2023","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"12","key":"2026052111520472500_ref46","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1093\/eurheartj\/ehae613","article-title":"Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial","volume":"46","author":"Mahaffey","year":"2025","journal-title":"Eur Heart J"},{"key":"2026052111520472500_ref47","first-page":"31","article-title":"Semaglutide in heart failure and atherosclerotic cardiovascular disease: the current state-of-the-art","volume":"31","author":"Theodorakis","year":"2025","journal-title":"Heart Fail Rev"},{"key":"2026052111520472500_ref48","first-page":"07","article-title":"Fibroblast growth factor 23 and fibroblast growth factor receptor 4 promote cardiac metabolic remodeling in chronic kidney disease","volume":"07","author":"Fuchs","year":"2025","journal-title":"Kidney Int"},{"issue":"1","key":"2026052111520472500_ref49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41569-023-00903-0","article-title":"FGF23 and klotho at the intersection of kidney and cardiovascular disease","volume":"21","author":"Edmonston","year":"2024","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"2026052111520472500_ref50","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/hdi.12887","article-title":"Fibroblast growth factor 23 as a risk factor for cardiovascular events and mortality in patients in the EVOLVE trial","volume":"25","author":"Block","year":"2021","journal-title":"Hemodial Int"},{"issue":"11","key":"2026052111520472500_ref51","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjag051\/67363704\/zjag051.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjag051\/67363704\/zjag051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:52:08Z","timestamp":1779378728000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article\/doi\/10.1093\/jbmr\/zjag051\/8524487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjag051","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"article-number":"zjag051"}}